Table 6.

Study A: estimated mean values from mixed models of area under the curve of laboratory parameters and P values of specified comparisons, including period, treatment, and interaction term between period and treatment

P Value
OverallaMembrane Type (in HD)Treatment Modality
Dialyzer/ ModalityFX 100 HDFX CorDiax 100 HDFX CorDiax 100 HDFFX CorDiax 100 versus FX 100FX CorDiax 100 (HDF) versus FX CorDiax 100 (HD)
C3a, µg×min/L24,86424,78518,234<0.0010.96<0.001
C5a, µg×min/L44.5439.8124.75<0.0010.06<0.001
sC5b-9, µg×min/L80,70484,57965,631<0.0010.44<0.001
Leukocytes, 103×min/µl1338137113640.730.450.87
Elastase, µg×min/L914110,4487999<0.0010.002<0.001
Thrombocytes, 103×min/µl41,27142,45338,6310.0010.25<0.001
Kallikrein, IU×min/ml4106378335630.070.170.31
  • HD, hemodialysis; HDF, hemodiafiltration.

  • a The overall P value displays the P value for analyzing differences between all three groups.